{
    "2021-04-01": [
        [
            {
                "time": "2021-03-01",
                "original_text": "Pfizer and BioNTech's Coronavirus Vaccine Remains Effective for at Least 6 Months",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "effective",
                        "6 months"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-05",
                "original_text": "BioNTech Stock Hikes As Pfizer-Partnered Covid Vaccine Appears Durable",
                "features": {
                    "keywords": [
                        "BioNTech",
                        "stock",
                        "hikes",
                        "Pfizer",
                        "Covid",
                        "vaccine",
                        "durable"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-10",
                "original_text": "Pfizer Trials Show Vaccine Is Effective for At Least Six Months",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "trials",
                        "vaccine",
                        "effective",
                        "six months"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "UPDATE 3-Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "COVID-19",
                        "shot",
                        "91%",
                        "effective",
                        "South African variant"
                    ],
                    "sentiment_score": 0.88,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-20",
                "original_text": "Pfizer Suggests Covid Vaccine Can Tackle South Africa Variant; BioNTech Pops",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Covid",
                        "vaccine",
                        "South Africa Variant",
                        "BioNTech",
                        "pops"
                    ],
                    "sentiment_score": 0.87,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-25",
                "original_text": "Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "high efficacy",
                        "safety",
                        "six months",
                        "second dose",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}